{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:45:28Z","timestamp":1766040328018,"version":"3.48.0"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Rheumatic and autoimmune diseases represent one of the major causes of chronic joint and muscle pain, skin ulceration, and mental depression, significantly impairing patients' physical and psychological wellbeing as well as their quality of life. Current evidence suggests that hypoxia may play a role in the pathogenesis and progression of rheumatic and autoimmune diseases and their associated complications. Hypoxia can induce pathological cellular stress, thereby triggering cell death. Hyperbaric oxygen therapy (HBOT) is a well-established, effective, and safe method for significantly increasing dissolved oxygen content in plasma and arterial oxygen partial pressure. Based on a comprehensive review of all relevant literature published in the past decade and indexed in PubMed regarding HBOT for rheumatic and autoimmune diseases, the following findings were observed: HBOT demonstrated an efficacy rate of 87.5%\u2212100% in treating rheumatic and autoimmune diseases complicated by skin ulcers. For patients with fibromyalgia syndrome (FMS), the pain relief rate ranged from 87.5 to 100%. Additionally, HBOT exhibited favorable therapeutic effects in cases involving sensorineural hearing loss and acute macular neuroretinopathy secondary to rheumatic and autoimmune diseases. Regarding safety, adverse effects were reported in seven studies, primarily including mild barotrauma, tinnitus, headache, and claustrophobia. All adverse events resolved upon discontinuation of HBOT, and no severe adverse reactions were documented.<\/jats:p>","DOI":"10.3389\/fmed.2025.1706637","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:41:23Z","timestamp":1766040083000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical efficacy and mechanisms of hyperbaric oxygen therapy in the treatment of rheumatic and immune diseases"],"prefix":"10.3389","volume":"12","author":[{"given":"Jinying","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinglu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"B1","volume-title":"Hyperbaric Physics","author":"Jones","year":"2025"},{"key":"B2","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.biopha.2018.10.142","article-title":"Hyperbaric oxygen therapy: antimicrobial mechanisms and clinical application for infections","volume":"109","author":"Memar","year":"2019","journal-title":"Biomed Pharmacother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.12809\/hkmj176875","article-title":"Hyperbaric oxygen therapy: its use in medical emergencies and its development in Hong Kong","volume":"24","author":"Leung","year":"2018","journal-title":"Hong Kong Med J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"118246","DOI":"10.1016\/j.lfs.2020.118246","article-title":"Hyperbaric oxygen potentiates diabetic wound healing by promoting fibroblast cell proliferation and endothelial cell angiogenesis","volume":"259","author":"Huang","year":"2020","journal-title":"Life Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jcmgh.2022.03.008","article-title":"The host-microbiome response to hyperbaric oxygen therapy in ulcerative colitis patients","volume":"14","author":"Gonzalez","year":"2022","journal-title":"Cell Mol Gastroenterol. Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s43465-023-00837-2","article-title":"Hyperbaric oxygen therapy in orthopaedics: an adjunct therapy with an emerging role","volume":"57","author":"Jeyaraman","year":"2023","journal-title":"Indian J Orthop"},{"key":"B7","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/cells9040880","article-title":"Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis","volume":"9","author":"Lin","year":"2020","journal-title":"Cells."},{"key":"B8","doi-asserted-by":"publisher","first-page":"101339","DOI":"10.1016\/j.smim.2019.101339","article-title":"Complement activation and regulation in rheumatic disease","volume":"45","author":"Dijkstra","year":"2019","journal-title":"Semin Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1368982","DOI":"10.3389\/fragi.2024.1368982","article-title":"Hyperbaric oxygen therapy: future prospects in regenerative therapy and anti-aging","volume":"5","author":"Gupta","year":"2024","journal-title":"Front Aging."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1007\/s10787-023-01232-x","article-title":"Ischemic tubular injury: oxygen-sensitive signals and metabolic reprogramming","volume":"31","author":"Rahbar Saadat","year":"2023","journal-title":"Inflammopharmacology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.metabol.2018.03.004","article-title":"Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-\u03baB pathway","volume":"83","author":"Chen","year":"2018","journal-title":"Metabolism."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e70384","DOI":"10.1111\/cns.70384","article-title":"Chronic intermittent hypoxia-induced neural injury: pathophysiology, neurodegenerative implications, and therapeutic insights","volume":"31","author":"Jia","year":"2025","journal-title":"CNS Neurosci Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.3390\/ijms22115703","article-title":"Cancer cell metabolism in hypoxia: role of HIF-1 as key regulator and therapeutic target","volume":"22","author":"Infantino","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41467-021-27944-8","article-title":"HIF-1 Interacts with TRIM28 and DNA-PK to release paused RNA polymerase II and activate target gene transcription in response to hypoxia","volume":"13","author":"Yang","year":"2022","journal-title":"Nat Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"110338","DOI":"10.1016\/j.biopha.2020.110338","article-title":"Oxygen homeostasis and cardiovascular disease: a role for HIF?","volume":"128","author":"Li","year":"2020","journal-title":"Biomed Pharmacother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/2045-9912.310057","article-title":"Therapeutic effects of hyperbaric oxygen: integrated review","volume":"11","author":"Sen","year":"2021","journal-title":"Med Gas Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"346e","DOI":"10.1097\/PRS.0000000000008758","article-title":"Hyperbaric oxygen therapy in management of diabetic foot ulcers: indocyanine green angiography may be used as a biomarker to analyze perfusion and predict response to treatment","volume":"149","author":"Mohammad","year":"2022","journal-title":"Plast Reconstr Surg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s11357-022-00707-z","article-title":"The potential of hyperbaric oxygen as a therapy for neurodegenerative diseases","volume":"45","author":"Mensah-Kane","year":"2023","journal-title":"GeroScience."},{"key":"B19","doi-asserted-by":"publisher","first-page":"11252","DOI":"10.1038\/s41598-022-15565-0","article-title":"Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial","volume":"12","author":"Zilberman-Itskovich","year":"2022","journal-title":"Sci Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1097\/AUD.0000000000001338","article-title":"Comparison of intratympanic steroid and hyperbaric oxygen salvage therapy hearing outcomes in idiopathic sudden sensorineural hearing loss: a retrospective study","volume":"44","author":"Ajduk","year":"2023","journal-title":"Ear Hear."},{"key":"B21","doi-asserted-by":"publisher","first-page":"102352","DOI":"10.1016\/j.redox.2022.102352","article-title":"Hyperbaric oxygen therapy for healthy aging: from mechanisms to therapeutics","volume":"53","author":"Fu","year":"2022","journal-title":"Redox Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s12016-020-08788-4","article-title":"Cutaneous vasculitis: review on diagnosis and clinicopathologic correlations","volume":"61","author":"Frumholtz","year":"2021","journal-title":"Clin Rev Allergy Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.mcna.2023.05.005","article-title":"Vasculitis: when to consider this diagnosis?","volume":"107","author":"Mishra","year":"2023","journal-title":"Med Clin North Am."},{"key":"B24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.28920\/dhm48.1.31-35","article-title":"Hyperbaric oxygen treatment in thromboangiitis obliterans: a retrospective clinical audit","volume":"48","author":"Hemsinli","year":"2018","journal-title":"Diving Hyperb. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/ijd.13570","article-title":"Hyperbaric oxygen therapy for chronic ulcers in systemic sclerosis - case series","volume":"56","author":"Mirasoglu","year":"2017","journal-title":"Int J Dermatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4750375","DOI":"10.1155\/2020\/4750375","article-title":"Successful use of hyperbaric oxygen as adjunctive therapy for a nonhealing venous ulcer in a patient with systemic sclerosis and pulmonary arterial hypertension: a case report and review of the literature","volume":"2020","author":"Biney","year":"2020","journal-title":"Case Rep Pulmonol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1177\/15347346221075873","article-title":"Chronic leg ulcer associated with cutaneous igg4-related disease","volume":"22","author":"Chen","year":"2023","journal-title":"Int J Low Extrem Wounds."},{"key":"B28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3109\/14756366.2012.759951","article-title":"Effects of alpha lipoic acid and its R+ enantiomer supplemented to hyperbaric oxygen therapy on interleukin-6, TNF-\u03b1 and EGF production in chronic leg wound healing","volume":"29","author":"Nasole","year":"2014","journal-title":"J Enzyme Inhib Med Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1365-2990.2005.00698.x","article-title":"Hyperbaric oxygen therapy reduces neuroinflammation and expression of matrix metalloproteinase-9 in the rat model of traumatic brain injury","volume":"32","author":"Vlodavsky","year":"2006","journal-title":"Neuropathol Appl Neurobiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.freeradbiomed.2025.01.056","article-title":"Hyperbaric oxygen therapy attenuated limb ischemia in mice with high-fat diet by restoring Sirtuin 1 and mitochondrial function","volume":"230","author":"Hong","year":"2025","journal-title":"Free Radic Biol Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0002-9610(05)81019-0","article-title":"Relationship of oxygen dose to angiogenesis induction in irradiated tissue","volume":"160","author":"Marx","year":"1990","journal-title":"Am J Surg."},{"key":"B32","doi-asserted-by":"publisher","first-page":"995","DOI":"10.3389\/fphys.2018.00995","article-title":"Hyperbaric oxygen increases stem cell proliferation, angiogenesis and wound-healing ability of WJ-MSCs in diabetic mice","volume":"9","author":"Pe\u00f1a-Villalobos","year":"2018","journal-title":"Front Physiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0163371","DOI":"10.1371\/journal.pone.0163371","article-title":"Antioxidant response of chronic wounds to hyperbaric oxygen therapy","volume":"11","author":"Sureda","year":"2016","journal-title":"PLoS ONE."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","article-title":"Chronic pain: an update on burden, best practices, and new advances","volume":"397","author":"Cohen","year":"2021","journal-title":"Lancet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/S0140-6736(21)00392-5","article-title":"Nociplastic pain: towards an understanding of prevalent pain conditions","volume":"397","author":"Fitzcharles","year":"2021","journal-title":"Lancet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41584-020-00506-w","article-title":"Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment","volume":"16","author":"Sarzi-Puttini","year":"2020","journal-title":"Nat Rev Rheumatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.medcli.2023.12.016","article-title":"Effects of a low-pressure hyperbaric oxygen therapy on psychological constructs related to pain and quality of life in women with fibromyalgia: a randomized clinical trial","volume":"162","author":"Izquierdo-Alventosa","year":"2024","journal-title":"Med Clin."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1093\/pm\/pnaa416","article-title":"Evaluation of a hyperbaric oxygen therapy intervention in individuals with fibromyalgia","volume":"22","author":"Curtis","year":"2021","journal-title":"Pain Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"11599","DOI":"10.1038\/s41598-024-62161-5","article-title":"Hyperbaric oxygen therapy vs. pharmacological intervention in adults with fibromyalgia related to childhood sexual abuse: prospective, randomized clinical trial","volume":"14","author":"Boussi-Gross","year":"2024","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1759720x20930493","DOI":"10.1177\/1759720X20930493","article-title":"Comparative study of the effectiveness of a low-pressure hyperbaric oxygen treatment and physical exercise in women with fibromyalgia: randomized clinical trial","volume":"12","author":"Izquierdo-Alventosa","year":"2020","journal-title":"Therap Adv Musculoskelet Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e062322","DOI":"10.1136\/bmjopen-2022-062322","article-title":"Efficacy and safety of hyperbaric oxygen therapy for fibromyalgia: a systematic review and meta-analysis","volume":"13","author":"Chen","year":"2023","journal-title":"BMJ Open."},{"key":"B42","first-page":"94","article-title":"Hyperbaric oxygen therapy in fibromyalgia and the diseases involving the central nervous system","volume":"38","author":"Atzeni","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"B43","first-page":"429","article-title":"The role of hyperbaric oxygen therapy in orthopedics and rheumatological diseases","volume":"19","author":"Barilaro","year":"2017","journal-title":"Israel Med Assoc J."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1582432","DOI":"10.1155\/2022\/1582432","article-title":"Oxidative stress in fibromyalgia: from pathology to treatment","volume":"2022","author":"Assavarittirong","year":"2022","journal-title":"Oxid Med Cell Longev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s12028-018-0577-x","article-title":"Hyperbaric oxygen protects against cerebral damage in permanent middle cerebral artery occlusion rats and inhibits autophagy activity","volume":"30","author":"Lu","year":"2019","journal-title":"Neurocrit Care."},{"key":"B46","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/0194599819859883","article-title":"Clinical practice guideline: sudden hearing loss (Update) executive summary","volume":"161","author":"Chandrasekhar","year":"2019","journal-title":"Otolaryngology."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1001\/jamaoto.2018.2133","article-title":"Addition of hyperbaric oxygen therapy vs medical therapy alone for idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis","volume":"144","author":"Rhee","year":"2018","journal-title":"JAMA Otolaryngol Head Neck Surg."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1453055","DOI":"10.3389\/fneur.2024.1453055","article-title":"Efficacy of hyperbaric oxygen therapy in treating sudden sensorineural hearing loss: an umbrella review","volume":"15","author":"Liu","year":"2024","journal-title":"Front Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.3390\/ijerph18094460","article-title":"The use of hyperbaric oxygen therapy and corticosteroid therapy in acute acoustic trauma: 15 years' experience at the Czech Military Health Service","volume":"18","author":"Holy","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B50","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/09273948.2022.2029497","article-title":"Hyperbaric oxygen therapy combined with immunosuppression for acute macular neuroretinopathy in systemic lupus erythematosus","volume":"31","author":"Shroff","year":"2023","journal-title":"Ocul Immunol Inflamm."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e13906","DOI":"10.1111\/1440-1681.13906","article-title":"Comparison of disease-modifying anti-rheumatic drugs and hyperbaric oxygen therapy in the experimental model of rheumatoid arthritis in rats","volume":"51","author":"Hallak","year":"2024","journal-title":"Clin Exp Pharmacol Physiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13256-017-1421-1","article-title":"Successful treatment with hyperbaric oxygen therapy for pneumatosis cystoides intestinalis as a complication of granulomatosis with polyangiitis: a case report","volume":"11","author":"Nakatani","year":"2017","journal-title":"J Med Case Rep."},{"key":"B53","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.5021\/ad.20.330","article-title":"A refractory livedoid vasculopathy accompanied by methylene tetrahydrofolate reductase gene polymorphism successfully treated with hyperbaric oxygen therapy","volume":"35","author":"Lee","year":"2023","journal-title":"Ann Dermatol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"103325","DOI":"10.1016\/j.annder.2024.103325","article-title":"Hyperbaric oxygen therapy enables pain reduction and healing in painful chronic wounds, including in calciphylaxis","volume":"151","author":"Pathault","year":"2024","journal-title":"Ann Dermatol Venereol."},{"key":"B55","first-page":"613","article-title":"Medium-pressure hyperbaric oxygen therapy for livedoid vasculopathy","volume":"82","author":"Herrera-S\u00e1nchez","year":"2022","journal-title":"Medicina."},{"key":"B56","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1177\/1534734616666866","article-title":"Hyperbaric oxygen therapy in the treatment of fontaine stage IV Thromboangiitis Obliterans","volume":"15","author":"Hemsinli","year":"2016","journal-title":"Int J Low Extrem Wounds."},{"key":"B57","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1177\/01455613211051660","article-title":"Bilateral sudden sensorineural hearing loss in patient with Beh\u00e7et disease","volume":"103","author":"Chuang","year":"2024","journal-title":"Ear Nose Throat J."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.3389\/fpsyg.2018.02495","article-title":"Hyperbaric oxygen therapy can induce neuroplasticity and significant clinical improvement in patients suffering from fibromyalgia with a history of childhood sexual abuse-randomized controlled trial","volume":"9","author":"Hadanny","year":"2018","journal-title":"Front Psychol."},{"key":"B59","first-page":"63","article-title":"Hyperbaric oxygen treatment of fibromyalgia: a prospective observational clinical study","volume":"37","author":"Atzeni","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e0127012","DOI":"10.1371\/journal.pone.0127012","article-title":"Hyperbaric oxygen therapy can diminish fibromyalgia syndrome\u2013prospective clinical trial","volume":"10","author":"Efrati","year":"2015","journal-title":"PLoS ONE."},{"key":"B61","first-page":"81","article-title":"T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy","volume":"37","author":"Guggino","year":"2019","journal-title":"Clin Exp Rheumatol."},{"key":"B62","first-page":"75","article-title":"Neuromuscular efficiency in fibromyalgia is improved by hyperbaric oxygen therapy: looking inside muscles by means of surface electromyography","volume":"37","author":"Casale","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12894-019-0545-6","article-title":"Clinical and morphological effects of hyperbaric oxygen therapy in patients with interstitial cystitis associated with fibromyalgia","volume":"19","author":"Bosco","year":"2019","journal-title":"BMC Urol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e0282406","DOI":"10.1371\/journal.pone.0282406","article-title":"Hyperbaric oxygen therapy compared to pharmacological intervention in fibromyalgia patients following traumatic brain injury: a randomized, controlled trial","volume":"18","author":"Ablin","year":"2023","journal-title":"PLoS ONE."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1706637\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:41:25Z","timestamp":1766040085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1706637\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":64,"alternative-id":["10.3389\/fmed.2025.1706637"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1706637","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"article-number":"1706637"}}